FITY.US Fifty 1 Labs, Inc.

Healthcare Drug Manufacturers - Specialty & Generic USA Stocks
0.0001 USD
Close of Nov 13, 2026
Market cap
USD 119K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is FITY.US undervalued?

Graham number

The Graham number of Fifty 1 Labs, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Fifty 1 Labs, Inc. fundamental analysis

No fundamental analysis for Fifty 1 Labs, Inc. yet.

Fifty 1 Labs, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Fifty 1 Labs, Inc.

Fifty 1 Labs, Inc., a biotechnology and life sciences company, which focuses on peptide products, peptide discovery, AI-enabled research, and clinical development in the United States. The company provides sports supplements; peptides; telepath products, as well as health and wellness solutions. It offers supplements such as, pre-workout formulas, BCAAS, ION+ electrolyte formula, turmeric gummies, and ashwagandha gummies. The company was formerly known as Consumer Automotive…

Full company profile